How Corbus Uses Synthetic Cannabinoids to Fight Diseases

The video discusses the endocannabinoid system and the role of different cannabinoids, including synthetic ones developed by Corbus Pharmaceuticals. Corbus focuses on rare autoimmune diseases, aiming to expand into more common conditions. The video also explores the potential for big pharmaceutical companies to enter the cannabinoid market and clarifies Corbus' position in the cannabis industry. It concludes with a discussion on the future of medicinal cannabis and the challenges of using plant extracts for disease treatment.

Why might targeting orphan diseases be a strategic choice for a company like Corbus?

What challenges does the medicinal cannabis industry face in treating difficult diseases?